清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Xinjia Dayuan San for MDR-GN pneumonia: A randomized controlled trial

医学 随机对照试验 辅助治疗 重症监护医学 临床试验 免疫调节 内科学 治疗效果 物理疗法 梅德林
作者
Zongchen Jiang,Zimin Yan,Qiong Li,Xiaoyu Liu,Ran Ji,Yan Deng,Jie Zhang,Wei Qian,Zhisong Wu,Yebeilei Yang,Xin Zhao,Wensheng Qi
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:148: 157411-157411
标识
DOI:10.1016/j.phymed.2025.157411
摘要

BACKGROUND: Multidrug-resistant Gram-negative (MDR-GN) pneumonia presents an urgent global health challenge, characterized by limited therapeutic options and high mortality rates. Traditional Chinese medicine (TCM) offers a rich source of multi-component interventions with potential multi-target effects, demanding rigorous evaluation as an alternative or adjunctive strategy. METHODS: This multicenter, randomized, double-blind, head-to-head, placebo-controlled clinical trial was conducted by 4 hospitals in China (June 2022 - March 2025), evaluated Xinjia Dayuan San (XJDS), a standardized TCM formulation, against standard broad-spectrum antibiotics (imipenem/cilastatin [I/C] or cefoperazone/sulbactam [C/S]) in 224 adult patients with confirmed MDR-GN pneumonia. Patients were randomized (1:1) within antibiotic strata to receive either XJDS granules (3 g BID) plus intravenous antibiotic placebo (normal saline) or XJDS placebo plus active antibiotic for 7 days. Primary endpoints were 28-day all-cause mortality and 7-day reduction in sputum bacterial load score (Day 0 minus Day 7, 0-3 scale). Key secondary endpoints included changes in Clinical Pulmonary Infection Score (CPIS) and inflammatory markers. Safety was assessed throughout. FINDINGS: In this trial of 224 critically ill patients, XJDS did not meet the primary endpoint of non-inferiority for 28-day all-cause mortality compared to standard antibiotics. However, XJDS demonstrated superiority in key secondary endpoints reflecting disease control. Specifically, XJDS resulted in a significantly greater reduction in the 7-day sputum bacterial load score versus both comparators (median reduction 1.0 vs 0.0, p < 0.001). This microbiological improvement was paralleled by a more rapid clinical stabilization; XJDS significantly accelerated the reduction in both the Clinical Pulmonary Infection Score (CPIS) and the APACHE-II score by Day 7 (p ≤ 0.001 for all comparisons). These clinical benefits were associated with a significant attenuation of key pro-inflammatory cytokines, including TNF-α and IL-1β. The safety profile was comparable between groups. INTERPRETATION: While not demonstrating definitive non-inferiority for 28-day mortality in this severe cohort, XJDS significantly improved microbiological clearance and clinical scores (CPIS, APACHE-II) in patients with MDR-GN pneumonia. Its benefits in immune modulation and microbial control, coupled with a comparable safety profile and rigorous standardization, suggest XJDS warrants further investigation as a promising adjunctive therapy as an alternative or adjunctive therapeutic option in managing critical drug-resistant infections. Further research into its precise mechanisms and clinical applications is warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
文2026完成签到,获得积分10
2秒前
梁瘦瘦完成签到,获得积分10
4秒前
六包辣条完成签到 ,获得积分10
4秒前
lay完成签到,获得积分10
4秒前
激情的三毒完成签到,获得积分10
7秒前
SUNNYONE完成签到 ,获得积分10
8秒前
ichenjun发布了新的文献求助10
9秒前
10秒前
11秒前
ichenjun发布了新的文献求助10
13秒前
ichenjun发布了新的文献求助10
17秒前
24秒前
Jack_20708124完成签到 ,获得积分10
25秒前
灵巧怀曼完成签到,获得积分10
32秒前
36秒前
着急的靖柔完成签到,获得积分10
39秒前
贪玩初彤完成签到 ,获得积分10
47秒前
51秒前
LRRRrRT发布了新的文献求助10
53秒前
Vivi完成签到 ,获得积分10
57秒前
小豆爱科研完成签到,获得积分10
57秒前
冥土追魂发布了新的文献求助10
58秒前
LINDENG2004完成签到 ,获得积分10
59秒前
邓洁宜完成签到,获得积分10
1分钟前
圆圆完成签到 ,获得积分10
1分钟前
nianxunxi完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
可靠的夕阳完成签到,获得积分10
1分钟前
Alvin完成签到 ,获得积分10
1分钟前
伶俐鞋子完成签到,获得积分10
1分钟前
无限白安完成签到,获得积分10
1分钟前
1分钟前
俏皮诺言完成签到,获得积分10
1分钟前
滕皓轩完成签到 ,获得积分20
1分钟前
等一下疾风劲草完成签到,获得积分10
1分钟前
rockyshi完成签到 ,获得积分10
1分钟前
Lucky完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166463
求助须知:如何正确求助?哪些是违规求助? 9559520
关于积分的说明 21750530
捐赠科研通 7757265
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553511
邀请新用户注册赠送积分活动 2473845